Study Evaluating Prevenar Immunogenicity in High Risk Children
Clinical trial NCT00581620 · COMPLETED
Trial details
- NCT number
- NCT00581620
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.